Pharma channel feed

Con­tin­u­ing to chart post-Covid path, Mod­er­na will build new sci­ence cen­ter near Mass­a­chu­setts head­quar­ters

4 years ago

FDA ap­proves Mirum Phar­ma's first treat­ment for rare pe­di­atric bile duct dis­ease

4 years ago
FDA+

Ma­jor Mass­a­chu­setts hos­pi­tals de­cide against us­ing Bio­gen's Aduhelm, with the help of a for­mer FDA ad­comm mem­ber

4 years ago

In bid to at­tract more R&D in­no­va­tion, Eu­rope looks to rewrite its phar­ma leg­is­la­tion

4 years ago

Gilead, Bris­tol My­ers face law­suit from ma­jor phar­ma­cies over HIV gener­ic drug de­lays

4 years ago

Ab­b­Vie clos­es in on Bio­haven with new mi­graine pre­ven­tion OK for oral CGRP drug

4 years ago
FDA+

As sup­ply chain wor­ries ease up, Big Phar­ma CEOs have a new top con­cern: re­cruit­ing and keep­ing em­ploy­ees

4 years ago
People

Zio­pharm lays off half its staff af­ter man­u­fac­tur­ing is­sues force de­lays

4 years ago
People
Manufacturing

Mer­ck emerges as lead bid­der in po­ten­tial Ac­celeron buy­out with deal pos­si­ble this week — re­port

4 years ago
Deals

Bio­gen can't es­cape co­pay kick­back law­suits as Hu­mana al­leges 'seed­ing and sweep­ing' scheme

4 years ago

Mer­ck touts a con­fir­ma­to­ry Keytru­da win for liv­er can­cer as 'dan­gling' ac­cel­er­at­ed ap­proval saga march­es on

4 years ago
R&D

No­vo Nordisk set­tles in­sulin pric­ing suit for $100M

4 years ago

Mer­ck, Pfiz­er end patent feud over pneu­mo­coc­cal vac­cines with roy­al­ty-cen­tered set­tle­ment

4 years ago

HHS lines up No­var­tis, Lil­ly, As­traZeneca and 3 oth­er drug­mak­ers for fines due to drug dis­count vi­o­la­tions

4 years ago

Fol­low­ing con­tro­ver­sial Aduhelm ap­proval, DC-based neu­rol­o­gy cen­ter bans Bio­gen rep­re­sen­ta­tives from its of­fices — re­port

4 years ago
FDA+

Roche's Foun­da­tion Med­i­cine is get­ting a new 16-sto­ry home in Boston's Sea­port Dis­trict

4 years ago

The fire un­der Glax­o­SmithK­line's Em­ma Walm­s­ley grows as an­oth­er well-known ac­tivist in­vestor grabs its pitch­fork — re­port

4 years ago
People

Aerie fires CEO af­ter lead pro­gram flop, com­ments about pri­ma­ry end­points be­ing 'not re­quired'

4 years ago
People

Ex-My­lan em­ploy­ee pleads guilty to in­sid­er trad­ing, il­le­gal­ly deal­ing on FDA ap­provals, earn­ings and Up­john merg­er

4 years ago

Boston, the Bay Area and San Diego dom­i­nate the life sci­ences re­al es­tate mar­ket. Where to next?

4 years ago

Bris­tol My­ers rolls out 3-year mesothe­lioma da­ta for Op­di­vo/Yer­voy in first look at ES­MO slate

4 years ago

Biden calls on Con­gress to al­low Medicare drug price ne­go­ti­a­tions

4 years ago
R&D

Bio­gen CEO Vounatsos laments 'con­fu­sion' and 'mis­in­for­ma­tion' lead­ing to chal­lenges with Aduhelm up­take

4 years ago

Strug­gling Acor­da team brings out the axe — yet again — to chop away at costs as sales sput­ter

4 years ago
First page Previous page 232233234235236237238 Next page Last page
A service from the Financial Times